Literature DB >> 24406799

Higher levels of spontaneous breathing induce lung recruitment and reduce global stress/strain in experimental lung injury.

Andreas Güldner1, Anja Braune, Nadja Carvalho, Alessandro Beda, Stefan Zeidler, Bärbel Wiedemann, Gerd Wunderlich, Michael Andreeff, Christopher Uhlig, Peter M Spieth, Thea Koch, Paolo Pelosi, Jörg Kotzerke, Marcelo Gama de Abreu.   

Abstract

BACKGROUND: Spontaneous breathing (SB) in the early phase of the acute respiratory distress syndrome is controversial. Biphasic positive airway pressure/airway pressure release ventilation (BIPAP/APRV) is commonly used, but the level of SB necessary to maximize potential beneficial effects is unknown.
METHODS: Experimental acute respiratory distress syndrome was induced by saline lung lavage in anesthetized and mechanically ventilated pigs (n = 12). By using a Latin square and crossover design, animals were ventilated with BIPAP/APRV at four different levels of SB in total minute ventilation (60 min each): (1) 0% (BIPAP/APRV0%); (2) greater than 0 to 30% (BIPAP/APRV>0-30%); (3) greater than 30 to 60% (BIPAP/APRV>30-60%); and (4) greater than 60% (BIPAP/APRV>60%). Gas exchange, hemodynamics, and respiratory variables were measured. Lung aeration was assessed by high-resolution computed tomography. The distribution of perfusion was marked with Ga-labeled microspheres and evaluated by positron emission tomography.
RESULTS: The authors found that higher levels of SB during BIPAP/APRV (1) improved oxygenation; (2) decreased mean transpulmonary pressure (stress) despite increased inspiratory effort; (3) reduced nonaerated lung tissue, with minimal changes in the distribution of perfusion, resulting in decreased low aeration/perfusion zones; and (4) decreased global strain (mean ± SD) (BIPAP/APRV0%: 1.39 ± 0.08; BIPAP/APRV0-30%: 1.33 ± 0.03; BIPAP/APRV30-60%: 1.27 ± 0.06; BIPAP/APRV>60%: 1.25 ± 0.04, P < 0.05 all vs. BIPAP/APRV0%, and BIPAP/APRV>60% vs. BIPAP/APRV0-30%).
CONCLUSIONS: In a saline lung lavage model of experimental acute respiratory distress syndrome in pigs, levels of SB during BIPAP/APRV higher than currently recommended for clinical practice, that is, 10 to 30%, improve oxygenation by increasing aeration in dependent lung zones without relevant redistribution of perfusion. In presence of lung recruitment, higher levels of SB reduce global stress and strain despite an increase in inspiratory effort.

Entities:  

Mesh:

Year:  2014        PMID: 24406799     DOI: 10.1097/ALN.0000000000000124

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  16 in total

1.  Effects of Positive End-Expiratory Pressure and Spontaneous Breathing Activity on Regional Lung Inflammation in Experimental Acute Respiratory Distress Syndrome.

Authors:  Thomas Kiss; Thomas Bluth; Anja Braune; Robert Huhle; Axel Denz; Moritz Herzog; Johannes Herold; Luigi Vivona; Marco Millone; Alice Bergamaschi; Michael Andreeff; Martin Scharffenberg; Jakob Wittenstein; Marcos F Vidal Melo; Thea Koch; Patricia R M Rocco; Paolo Pelosi; Jörg Kotzerke; Marcelo Gama de Abreu
Journal:  Crit Care Med       Date:  2019-04       Impact factor: 7.598

Review 2.  [Acute respiratory distress syndrome : Basic principles and treatment].

Authors:  P M Spieth; A Güldner; M Gama de Abreu
Journal:  Anaesthesist       Date:  2017-07       Impact factor: 1.041

3.  Lung protective ventilation (ARDSNet) versus airway pressure release ventilation: ventilatory management in a combined model of acute lung and brain injury.

Authors:  Stephen W Davies; Kenji L Leonard; Randall K Falls; Ronald P Mageau; Jimmy T Efird; Joseph P Hollowell; Wayne E Trainor; Hilal A Kanaan; Robert C Hickner; Robert G Sawyer; Nathaniel R Poulin; Brett H Waibel; Eric A Toschlog
Journal:  J Trauma Acute Care Surg       Date:  2015-02       Impact factor: 3.313

4.  Therapeutic range of spontaneous breathing during mechanical ventilation.

Authors:  Matthias Eikermann; Marcos F Vidal Melo
Journal:  Anesthesiology       Date:  2014-03       Impact factor: 7.892

5.  Acute respiratory distress syndrome: we can't miss regional lung perfusion!

Authors:  Paolo Pelosi; Marcelo Gama de Abreu
Journal:  BMC Anesthesiol       Date:  2015-03-18       Impact factor: 2.217

6.  Early application of airway pressure release ventilation may reduce the duration of mechanical ventilation in acute respiratory distress syndrome.

Authors:  Yongfang Zhou; Xiaodong Jin; Yinxia Lv; Peng Wang; Yunqing Yang; Guopeng Liang; Bo Wang; Yan Kang
Journal:  Intensive Care Med       Date:  2017-09-22       Impact factor: 17.440

7.  Effects of pressure support and pressure-controlled ventilation on lung damage in a model of mild extrapulmonary acute lung injury with intra-abdominal hypertension.

Authors:  Cintia L Santos; Raquel S Santos; Lillian Moraes; Cynthia S Samary; Nathane S Felix; Johnatas D Silva; Marcelo M Morales; Robert Huhle; Marcelo G Abreu; Alberto Schanaider; Pedro L Silva; Paolo Pelosi; Patricia R M Rocco
Journal:  PLoS One       Date:  2017-05-25       Impact factor: 3.240

8.  Effect of spontaneous breathing on ventilator-free days in critically ill patients-an analysis of patients in a large observational cohort.

Authors:  Aline Mela Dos Reis; Thais Dias Midega; Rodrigo Octavio Deliberato; Alistair Ew Johnson; Lucas Bulgarelli; Thiago Domingos Correa; Leo Anthony Celi; Paolo Pelosi; Marcelo Gama De Abreu; Marcus J Schultz; Ary Serpa Neto
Journal:  Ann Transl Med       Date:  2021-05

Review 9.  The 30-year evolution of airway pressure release ventilation (APRV).

Authors:  Sumeet V Jain; Michaela Kollisch-Singule; Benjamin Sadowitz; Luke Dombert; Josh Satalin; Penny Andrews; Louis A Gatto; Gary F Nieman; Nader M Habashi
Journal:  Intensive Care Med Exp       Date:  2016-05-20

10.  Airway Pressure Release Ventilation Mode Improves Circulatory and Respiratory Function in Patients After Cardiopulmonary Bypass, a Randomized Trial.

Authors:  Huiqing Ge; Ling Lin; Ying Xu; Peifeng Xu; Kailiang Duan; Qing Pan; Kejing Ying
Journal:  Front Physiol       Date:  2021-06-03       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.